UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 46

of 'Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease'

46
TI
ICON-6: the danger of changing study design midstream.
AU
Norrie J
SO
Lancet. 2016;387(10023):1031.
 
AD
Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen AB25 2ZD, UK. Electronic address: j.norrie@abdn.ac.uk.
PMID